Life after SAINT

MeSH terms

• Albumins / therapeutic use
• Antioxidants / administration & dosage
• Antioxidants / therapeutic use
• Benzenesulfonates / administration & dosage
• Benzenesulfonates / therapeutic use*
• Caffeine / therapeutic use
• Cerebral Hemorrhage / chemically induced
• Cerebral Hemorrhage / prevention & control
• Clinical Trials, Phase II as Topic* / methods
• Clinical Trials, Phase II as Topic* / statistics & numerical data
• Double-Blind Method
• Drug Combinations
• Drug Therapy, Combination
• Ethanol / therapeutic use
• Fibrinolytic Agents / administration & dosage
• Fibrinolytic Agents / adverse effects
• Fibrinolytic Agents / therapeutic use
• Glyburide / therapeutic use
• Humans
• Magnesium / therapeutic use
• Neurons / pathology
• Neuroprotective Agents / administration & dosage
• Neuroprotective Agents / pharmacokinetics
• Neuroprotective Agents / therapeutic use*
• Recombinant Proteins / administration & dosage
• Recombinant Proteins / adverse effects
• Recombinant Proteins / therapeutic use
• Reperfusion
• Stroke / drug therapy*
• Stroke / pathology
• Thrombolytic Therapy
• Tissue Plasminogen Activator / administration & dosage
• Tissue Plasminogen Activator / adverse effects
• Tissue Plasminogen Activator / therapeutic use
• Treatment Failure